bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.040
+0.010 (0.97%)
At close: Mar 6, 2026, 4:00 PM EST
1.012
-0.028 (-2.72%)
After-hours: Mar 6, 2026, 7:12 PM EST

bioAffinity Technologies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-14.74-9.04-7.94-8.15-6.33-7.27
Depreciation & Amortization
0.530.610.250.0100.02
Stock-Based Compensation
0.840.990.750.250.040.28
Other Adjustments
3.28--3.713.64.28
Change in Receivables
0.88-0.330.31-0.01--
Changes in Inventories
-0.01-0.01-0.01-0.01--
Changes in Accounts Payable
0.160.38-0.010.110.040.09
Changes in Accrued Expenses
0.080.250.360.070.110.01
Changes in Unearned Revenue
0.01-0.010.03---
Changes in Other Operating Activities
-0.01-0.110.22-0.050.490.38
Operating Cash Flow
-8.45-7.26-6.04-4.07-2.05-2.21
Capital Expenditures
-0.06-0.08-0.02-0.22--0
Payments for Business Acquisitions
---2.19---
Investing Cash Flow
-0.06-0.08-2.21-0.22--0
Long-Term Debt Issued
-0.10.19-1.283.511.72
Long-Term Debt Repaid
-0.01--0.25-0.69--
Net Long-Term Debt Issued (Repaid)
-0.110.19-0.250.583.511.72
Issuance of Common Stock
8.815.8-13.82--
Net Common Stock Issued (Repurchased)
8.815.8-13.82--
Other Financing Activities
-0.34-0.36-0.09-0.06-0.18-
Financing Cash Flow
15.425.63-0.3414.343.331.72
Net Cash Flow
6.72-1.72-8.5910.051.28-0.5
Free Cash Flow
-8.51-7.34-6.06-4.29-2.05-2.21
FCF Margin
-125.53%-78.44%-239.32%-89336.50%--
Free Cash Flow Per Share
-11.72-18.17-20.79-28.61--
Levered Free Cash Flow
-14.14-7.81-7.37-7.66-2.18-5.05
Unlevered Free Cash Flow
-9.68-7.91-7.14-4.1-1.57-2.1
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q